CN101904411B - 一种复合微生态制剂及其应用 - Google Patents
一种复合微生态制剂及其应用 Download PDFInfo
- Publication number
- CN101904411B CN101904411B CN2010102326002A CN201010232600A CN101904411B CN 101904411 B CN101904411 B CN 101904411B CN 2010102326002 A CN2010102326002 A CN 2010102326002A CN 201010232600 A CN201010232600 A CN 201010232600A CN 101904411 B CN101904411 B CN 101904411B
- Authority
- CN
- China
- Prior art keywords
- preparation
- powder
- cgmcc
- composite microbial
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002131 composite material Substances 0.000 title abstract 7
- 230000000813 microbial effect Effects 0.000 title abstract 7
- 239000000843 powder Substances 0.000 claims abstract description 81
- 241000894006 Bacteria Species 0.000 claims abstract description 72
- 241000194108 Bacillus licheniformis Species 0.000 claims abstract description 43
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 42
- 241000194032 Enterococcus faecalis Species 0.000 claims abstract description 35
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 26
- 229940032049 enterococcus faecalis Drugs 0.000 claims abstract description 24
- 241001465754 Metazoa Species 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims description 134
- 150000001875 compounds Chemical class 0.000 claims description 62
- 239000000203 mixture Substances 0.000 claims description 18
- 240000008042 Zea mays Species 0.000 claims description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 8
- 235000013312 flour Nutrition 0.000 claims description 8
- 239000004575 stone Substances 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 4
- 235000009973 maize Nutrition 0.000 claims description 4
- 235000012054 meals Nutrition 0.000 claims description 4
- 229940103272 aluminum potassium sulfate Drugs 0.000 claims description 3
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 235000013601 eggs Nutrition 0.000 abstract description 19
- 235000018291 probiotics Nutrition 0.000 abstract description 15
- 239000006041 probiotic Substances 0.000 abstract description 14
- 244000144977 poultry Species 0.000 abstract description 12
- 244000063299 Bacillus subtilis Species 0.000 abstract description 11
- 229940099352 cholate Drugs 0.000 abstract description 11
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 abstract description 11
- 240000001046 Lactobacillus acidophilus Species 0.000 abstract description 9
- 239000002253 acid Substances 0.000 abstract description 7
- 102000004190 Enzymes Human genes 0.000 abstract description 6
- 108090000790 Enzymes Proteins 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 6
- 235000013372 meat Nutrition 0.000 abstract description 6
- 241000894007 species Species 0.000 abstract description 6
- 235000014469 Bacillus subtilis Nutrition 0.000 abstract description 5
- 239000003242 anti bacterial agent Substances 0.000 abstract description 5
- 229940088710 antibiotic agent Drugs 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 244000052616 bacterial pathogen Species 0.000 abstract description 4
- 230000012010 growth Effects 0.000 abstract description 4
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 abstract description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 abstract description 3
- 244000144972 livestock Species 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 235000013336 milk Nutrition 0.000 abstract description 2
- 210000004080 milk Anatomy 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 6
- 208000035240 Disease Resistance Diseases 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 87
- 238000000855 fermentation Methods 0.000 description 29
- 230000004151 fermentation Effects 0.000 description 29
- 239000002609 medium Substances 0.000 description 27
- 230000001580 bacterial effect Effects 0.000 description 26
- 239000001963 growth medium Substances 0.000 description 26
- 230000004083 survival effect Effects 0.000 description 23
- 238000000034 method Methods 0.000 description 21
- 239000000243 solution Substances 0.000 description 18
- 235000014590 basal diet Nutrition 0.000 description 17
- 230000002354 daily effect Effects 0.000 description 17
- 238000011081 inoculation Methods 0.000 description 15
- 230000003115 biocidal effect Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 238000004108 freeze drying Methods 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 206010012735 Diarrhoea Diseases 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 230000003716 rejuvenation Effects 0.000 description 12
- 238000004321 preservation Methods 0.000 description 11
- 239000012530 fluid Substances 0.000 description 10
- 239000002054 inoculum Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 230000037396 body weight Effects 0.000 description 9
- 210000004051 gastric juice Anatomy 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 8
- 238000011218 seed culture Methods 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 230000004913 activation Effects 0.000 description 7
- 238000007726 management method Methods 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 238000004088 simulation Methods 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 206010059866 Drug resistance Diseases 0.000 description 6
- 239000005913 Maltodextrin Substances 0.000 description 6
- 229920002774 Maltodextrin Polymers 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 6
- 235000007164 Oryza sativa Nutrition 0.000 description 6
- 238000009395 breeding Methods 0.000 description 6
- 230000001488 breeding effect Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- 229940035034 maltodextrin Drugs 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 238000007747 plating Methods 0.000 description 6
- 235000009566 rice Nutrition 0.000 description 6
- 235000020183 skimmed milk Nutrition 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- 244000046052 Phaseolus vulgaris Species 0.000 description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 5
- 208000021017 Weight Gain Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000000941 bile Anatomy 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 235000021050 feed intake Nutrition 0.000 description 5
- 238000000386 microscopy Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000019786 weight gain Nutrition 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 4
- 102000013142 Amylases Human genes 0.000 description 4
- 108010065511 Amylases Proteins 0.000 description 4
- 235000010894 Artemisia argyi Nutrition 0.000 description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 241000726221 Gemma Species 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000019418 amylase Nutrition 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 244000030166 artemisia Species 0.000 description 4
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000011167 hydrochloric acid Nutrition 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000013923 monosodium glutamate Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 238000013207 serial dilution Methods 0.000 description 4
- 229940073490 sodium glutamate Drugs 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 230000001228 trophic effect Effects 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 229910021536 Zeolite Inorganic materials 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 235000006109 methionine Nutrition 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000010457 zeolite Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 108010001478 Bacitracin Proteins 0.000 description 2
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 description 2
- 241000194031 Enterococcus faecium Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 235000019733 Fish meal Nutrition 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 2
- MVTQIFVKRXBCHS-SMMNFGSLSA-N N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone Chemical compound CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c2coc(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)n2.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 MVTQIFVKRXBCHS-SMMNFGSLSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 235000002597 Solanum melongena Nutrition 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 108010080702 Virginiamycin Proteins 0.000 description 2
- 239000004188 Virginiamycin Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- XKNKHVGWJDPIRJ-UHFFFAOYSA-N arsanilic acid Chemical compound NC1=CC=C([As](O)(O)=O)C=C1 XKNKHVGWJDPIRJ-UHFFFAOYSA-N 0.000 description 2
- 229950002705 arsanilic acid Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229960005364 bacitracin zinc Drugs 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 239000003833 bile salt Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 229960000740 enrofloxacin Drugs 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000004467 fishmeal Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000003736 gastrointestinal content Anatomy 0.000 description 2
- 238000012812 general test Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- 239000003262 industrial enzyme Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229950007634 kitasamycin Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- XYJOGTQLTFNMQG-KJHBSLKPSA-N leucomycin V Chemical compound CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1 XYJOGTQLTFNMQG-KJHBSLKPSA-N 0.000 description 2
- 229960005287 lincomycin Drugs 0.000 description 2
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 235000019371 penicillin G benzathine Nutrition 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229960003842 virginiamycin Drugs 0.000 description 2
- 235000019373 virginiamycin Nutrition 0.000 description 2
- 235000015099 wheat brans Nutrition 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- UCRLQOPRDMGYOA-DFTDUNEMSA-L zinc;(4r)-4-[[(2s)-2-[[(4r)-2-[(1s,2s)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2s,3s)-1-[[(3s,6r,9s,12r,15s,18r,21s)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2s)-butan-2-yl]-6-(carbox Chemical compound [Zn+2].C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC([O-])=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N[C@H](CC([O-])=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 UCRLQOPRDMGYOA-DFTDUNEMSA-L 0.000 description 2
- WTLNOANVTIKPEE-UHFFFAOYSA-N 2-acetyloxypropanoic acid Chemical compound OC(=O)C(C)OC(C)=O WTLNOANVTIKPEE-UHFFFAOYSA-N 0.000 description 1
- WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000003616 anti-epidemic effect Effects 0.000 description 1
- 229940097974 biotin 0.3 mg Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- VYVRIXWNTVOIRD-LRHBOZQDSA-N ciguatoxin CTX1B Chemical compound C([C@@]12[C@@H](C)[C@@H]([C@@H]3[C@H]([C@H]([C@H](C)[C@H]4O[C@H]5C[C@@H](C)C[C@H]6O[C@@]7(C)[C@H](O)C[C@H]8O[C@H]9C=C[C@H]%10O[C@H]%11C[C@@H]%12[C@H]([C@@H]([C@H]%13O[C@H](C=CC[C@@H]%13O%12)\C=C\[C@H](O)CO)O)O[C@@H]%11C=C[C@@H]%10O[C@@H]9C\C=C/C[C@@H]8O[C@@H]7C[C@@H]6O[C@@H]5C[C@@H]4O3)O)O2)C)[C@H](O)CO1 VYVRIXWNTVOIRD-LRHBOZQDSA-N 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940047766 co-trimoxazole Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 230000000816 effect on animals Effects 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000008642 heat stress Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 238000009304 pastoral farming Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000008400 supply water Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Abstract
Description
成分 | 含量(%) | 营养成分 | |
玉米 | 56.0 | 代谢能(MJ/kg) | 12.59 |
豆粕 | 14.6 | 粗蛋白(%) | 17.06 |
菜粕 | 3.4 | 钙(%) | 3.57 |
花生饼 | 3.0 | 总磷(%) | 0.55 |
鱼粉 | 2.0 | 蛋氨酸(%) | 0.738 |
玉米蛋白粉 | 2.0 | 蛋氨酸+胱氨酸(%) | 0.676 |
酒精蛋白粉 | 5.0 | ||
石粉 | 5.8 | ||
沸石 | 1.0 | ||
磷酸氢钙 | 1.8 | ||
预混料 | 5 |
日粮组成 | 0~21日龄(%) | 22~42日龄(%) |
玉米 | 57.9 | 62.3 |
豆粕 | 32.0 | 28.8 |
鱼粉 | 3.0 | 2.0 |
石粉 | 0.9 | 0.9 |
磷酸氢钙 | 1.4 | 1.4 |
食盐 | 0.3 | 0.3 |
豆油 | 3.5 | 3.3 |
预混料 | 1.0 | 1.0 |
ME(MJ/Kg) | 12.47 | 12.59 |
CP(%) | 20.62 | 19.0 |
Ca(%) | 0.97 | 0.89 |
有效P(%) | 0.50 | 0.46 |
Lys(%) | 1.05 | 0.94 |
Met(%) | 0.36 | 0.33 |
对照组 | 试验组1 | 试验组II | ||
0~21日龄 | 始重 | 44.13±1.14 | 44.25±0.57 | 44.13±1.21 |
末重 | 474.82±11.61 | 515.65±16.29 | 526.31±18.58 | |
增重 | 430.69±11.98 | 471.40±16.57 | 482.18±17.30 | |
22~42日龄 | 末重 | 1654.09±45.18 | 1692.89±29.25 | 1760.41±50.14 |
增重 | 1179.27±44.75 | 1177.24±30.64 | 1234.10±53.13 |
对照组 | 试验组1 | 试验组II | |
0~21日龄 | 918.78±19.85 | 899.44±14.90 | 750.28±28.83 |
22~42日龄 | 3172.33±47.70 | 2715.76±106.84 | 3055.59±55.57 |
组别 | 全期增重(克/只) | 全期耗料(克/只) | 料重比 | 死亡率(%) |
试验组1 | 2073.68±89.83 | 4595.90±149.60 | 2.22±0.04 | 2.35 |
试验组II | 2115.97±29.57 | 4580.09±47.27 | 2.17±0.04 | 1.65 |
对照组 | 1880.88±33.05 | 4519.75±40.76 | 2.40±0.04 | 9.65 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102326002A CN101904411B (zh) | 2008-05-14 | 2008-05-14 | 一种复合微生态制剂及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102326002A CN101904411B (zh) | 2008-05-14 | 2008-05-14 | 一种复合微生态制剂及其应用 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101065205A Division CN101580799B (zh) | 2008-05-14 | 2008-05-14 | 一种复合微生态制剂及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101904411A CN101904411A (zh) | 2010-12-08 |
CN101904411B true CN101904411B (zh) | 2012-09-26 |
Family
ID=43260122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102326002A Active CN101904411B (zh) | 2008-05-14 | 2008-05-14 | 一种复合微生态制剂及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101904411B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102140041B (zh) * | 2011-01-18 | 2013-06-12 | 北京大北农科技集团股份有限公司 | 一种虾塘微生物肥料及其制备方法 |
CN102648733A (zh) * | 2011-02-24 | 2012-08-29 | 上海三智生物科技有限公司 | 对刺参生长和免疫力影响的复合微生物制剂 |
CN103181461A (zh) * | 2011-12-27 | 2013-07-03 | 北京资源亚太饲料科技有限公司 | 复合饲用微生态制剂及其制备方法 |
CN104293696B (zh) * | 2014-09-16 | 2016-08-17 | 李雪平 | 一株粪肠球菌hew-a131及其应用 |
CN105767603A (zh) * | 2016-04-06 | 2016-07-20 | 董燕声 | 一种养龟饲料添加剂 |
CN113892563B (zh) * | 2021-09-18 | 2023-08-25 | 江苏农林职业技术学院 | 一种缓解冷应激的复合益生菌制剂 |
CN114451485B (zh) * | 2022-01-26 | 2022-12-30 | 江苏省淡水水产研究所 | 中药多糖提取物冻干保护剂、直投发酵剂及其制备方法 |
-
2008
- 2008-05-14 CN CN2010102326002A patent/CN101904411B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101904411A (zh) | 2010-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101580799B (zh) | 一种复合微生态制剂及其应用 | |
CN101978849B (zh) | 一种复合微生态制剂及其应用 | |
CN102409015B (zh) | 一种复合微生态制剂及其在饲料添加剂中的应用和预混料 | |
CN103981118B (zh) | 一种枯草芽孢杆菌饲料添加剂及其制备方法和应用 | |
CN101530161B (zh) | 一种新型饲料添加剂及其制备方法 | |
CN102293340B (zh) | 一种可提高免疫功能的猪用复合预混料 | |
CN103966124A (zh) | 一种复合微生态制剂、添加剂及其预混料 | |
CN101638627B (zh) | 一株枯草芽孢杆菌及其在生物饲料添加剂中的应用 | |
CN102399733B (zh) | 约氏乳杆菌及其菌剂、应用和预混料 | |
CN104293696B (zh) | 一株粪肠球菌hew-a131及其应用 | |
CN101671638B (zh) | 一种双歧杆菌新菌株及其发酵制备方法与应用 | |
CN101904411B (zh) | 一种复合微生态制剂及其应用 | |
CN104397323A (zh) | 一种微生物饲料添加剂 | |
CN106962609A (zh) | 一种直投式生物发酵饲料添加剂及其制备方法和用途 | |
CN102742728A (zh) | 畜禽用复合益生菌饲料添加剂及预混料、浓缩料和配合料 | |
CN101971920B (zh) | 猪源罗伊氏乳酸杆菌冻干制剂及其制备方法 | |
CN102232479B (zh) | 一种芽孢杆菌饲料添加剂的制备工艺 | |
CN103907749A (zh) | 生物发酵活性载体型复合预混合饲料及其制备方法和应用 | |
CN101933558B (zh) | 一种复合微生态制剂及其应用 | |
CN102965316B (zh) | 含类细菌素与乳酸片球菌的饲料添加剂,预混料及配合料 | |
CN101392223A (zh) | 一种微生物饲料添加剂菌种的选育方法 | |
CN104872384A (zh) | 金针菇菇脚饲料添加剂 | |
CN102165995B (zh) | 一种猪用复合预混料 | |
CN102925374B (zh) | 酿酒酵母新菌株,及含有其的饲料添加剂,配合料 | |
CN105505808B (zh) | 一种复合微生态制剂、添加剂、预混料及配合料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20101208 Assignee: Zhejiang Dabeinong Agriculture Animal Husbandry Technology Co.,Ltd. Assignor: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. Contract record no.: 2012110000178 Denomination of invention: Composite microbial ecological agent and application thereof Granted publication date: 20120926 License type: Exclusive License Record date: 20121121 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191206 Address after: 363502, Fujian, Zhangzhou province Zhaoan County gold industrial concentration zone Co-patentee after: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. Patentee after: FUJIAN DABEINONG FISHERIES SCIENCE & TECHNOLOGY Co.,Ltd. Address before: 100080 Beijing City, Haidian District Zhongguancun street, No. 27 Zhongguancun building 14 DaBeiNong group Patentee before: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 363502 Jindu Industrial Concentration Zone, Zhaoan County, Zhangzhou City, Fujian Province Patentee after: Fujian Dabei nonghuayou Aquatic Technology Group Co.,Ltd. Patentee after: Beijing Da Bei agricultural science and technology group Limited by Share Ltd Address before: 363502 Jindu Industrial Concentration Zone, Zhaoan County, Zhangzhou City, Fujian Province Patentee before: FUJIAN DABEINONG FISHERIES SCIENCE & TECHNOLOGY Co.,Ltd. Patentee before: Beijing Da Bei agricultural science and technology group Limited by Share Ltd |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220630 Address after: 363502 Jindu Industrial Concentration Zone, Zhaoan County, Zhangzhou City, Fujian Province Patentee after: Fujian Dabei nonghuayou Aquatic Technology Group Co.,Ltd. Patentee after: LIANGPING DABEINONG FEED TECHNOLOGY CO.,LTD. Patentee after: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. Address before: 363502 Jindu Industrial Concentration Zone, Zhaoan County, Zhangzhou City, Fujian Province Patentee before: Fujian Dabei nonghuayou Aquatic Technology Group Co.,Ltd. Patentee before: Beijing Da Bei agricultural science and technology group Limited by Share Ltd |